Today's Daily Dose brings you news about Bristol-Myers' CheckMate -743 study results; Cyclacel Pharma's entry into COVID-19 drug bandwagon; Exelixis touching a new 52-week high and Novartis exploring anti-malaria drug for COVID-19.
from RTT - Biotech https://ift.tt/2VsxxHj
via IFTTT
No comments:
Post a Comment